270 related articles for article (PubMed ID: 10072536)
1. Coordinate involvement of invasin and Yop proteins in a Yersinia pseudotuberculosis-specific class I-restricted cytotoxic T cell-mediated response.
Falgarone G; Blanchard HS; Virecoulon F; Simonet M; Breban M
J Immunol; 1999 Mar; 162(5):2875-83. PubMed ID: 10072536
[TBL] [Abstract][Full Text] [Related]
2. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
Wiedig CA; Kramer U; Garbom S; Wolf-Watz H; Autenrieth IB
Vaccine; 2005 Oct; 23(42):4984-98. PubMed ID: 15985316
[TBL] [Abstract][Full Text] [Related]
3. The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity.
Håkansson S; Schesser K; Persson C; Galyov EE; Rosqvist R; Homblé F; Wolf-Watz H
EMBO J; 1996 Nov; 15(21):5812-23. PubMed ID: 8918459
[TBL] [Abstract][Full Text] [Related]
4. Influence of Yersinia pseudotuberculosis outer proteins (Yops) on interleukin-12, tumor necrosis factor alpha and nitric oxide production by peritoneal macrophages.
Monnazzi LG; Carlos IZ; de Medeiros BM
Immunol Lett; 2004 Jun; 94(1-2):91-8. PubMed ID: 15234540
[TBL] [Abstract][Full Text] [Related]
5. Molecular determinants of Yersinia pathogenesis.
Iriarte M; Cornelis GR
Microbiologia; 1996 Jun; 12(2):267-80. PubMed ID: 8767710
[TBL] [Abstract][Full Text] [Related]
6. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis.
Viboud GI; So SS; Ryndak MB; Bliska JB
Mol Microbiol; 2003 Mar; 47(5):1305-15. PubMed ID: 12603736
[TBL] [Abstract][Full Text] [Related]
7. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
Viboud GI; Mejía E; Bliska JB
Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Yersinia Yop-effector delivery by translocated YopE.
Aili M; Isaksson EL; Carlsson SE; Wolf-Watz H; Rosqvist R; Francis MS
Int J Med Microbiol; 2008 Apr; 298(3-4):183-92. PubMed ID: 17597003
[TBL] [Abstract][Full Text] [Related]
9. Cell type-specific effects of Yersinia pseudotuberculosis virulence effectors.
Fahlgren A; Westermark L; Akopyan K; Fällman M
Cell Microbiol; 2009 Dec; 11(12):1750-67. PubMed ID: 19681909
[TBL] [Abstract][Full Text] [Related]
10. Characterization of outer membrane proteins of Yersinia pestis and Yersinia pseudotuberculosis strains isolated from India.
Khushiramani R; Tuteja U; Shukla J; Batra HV
Indian J Exp Biol; 2004 May; 42(5):508-14. PubMed ID: 15233478
[TBL] [Abstract][Full Text] [Related]
11. [A comparative study of the role of the yadA, invA, and psaA genes in the pathogenicity of Yersinia pseudotuberculosis].
Karataev GI; Markov AR; Siniashina LN; Miller GG; Klitsunova NV; Titova IV; Semin EG; Goncharova NI; Pokrovskaia MS; Amelina IP; Amoako K; Smirnov GB
Mol Gen Mikrobiol Virusol; 2008; (4):10-8. PubMed ID: 19172873
[TBL] [Abstract][Full Text] [Related]
12. Type III secretion decreases bacterial and host survival following phagocytosis of Yersinia pseudotuberculosis by macrophages.
Zhang Y; Murtha J; Roberts MA; Siegel RM; Bliska JB
Infect Immun; 2008 Sep; 76(9):4299-310. PubMed ID: 18591234
[TBL] [Abstract][Full Text] [Related]
13. Influence of the Cpx extracytoplasmic-stress-responsive pathway on Yersinia sp.-eukaryotic cell contact.
Carlsson KE; Liu J; Edqvist PJ; Francis MS
Infect Immun; 2007 Sep; 75(9):4386-99. PubMed ID: 17620356
[TBL] [Abstract][Full Text] [Related]
14. Yersinia enterocolitica Yop mutants as oral live carrier vaccines.
Leibiger R; Niedung K; Geginat G; Heesemann J; Trülzsch K
Vaccine; 2008 Dec; 26(51):6664-70. PubMed ID: 18822332
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T-cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic rat.
Falgarone G; Blanchard HS; Riot B; Simonet M; Breban M
Infect Immun; 1999 Aug; 67(8):3773-9. PubMed ID: 10417137
[TBL] [Abstract][Full Text] [Related]
16. Status of YopM and YopN in the Yersinia Yop virulon: YopM of Y.enterocolitica is internalized inside the cytosol of PU5-1.8 macrophages by the YopB, D, N delivery apparatus.
Boland A; Sory MP; Iriarte M; Kerbourch C; Wattiau P; Cornelis GR
EMBO J; 1996 Oct; 15(19):5191-201. PubMed ID: 8895564
[TBL] [Abstract][Full Text] [Related]
17. A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.
Zhang Y; Mena P; Romanov G; Lin JS; Smiley ST; Bliska JB
Infect Immun; 2012 Jan; 80(1):206-14. PubMed ID: 22064714
[TBL] [Abstract][Full Text] [Related]
18. Cell invasion of Yersinia pseudotuberculosis by invasin and YadA requires protein kinase C, phospholipase C-gamma1 and Akt kinase.
Uliczka F; Kornprobst T; Eitel J; Schneider D; Dersch P
Cell Microbiol; 2009 Dec; 11(12):1782-801. PubMed ID: 19681907
[TBL] [Abstract][Full Text] [Related]
19. TyeA, a protein involved in control of Yop release and in translocation of Yersinia Yop effectors.
Iriarte M; Sory MP; Boland A; Boyd AP; Mills SD; Lambermont I; Cornelis GR
EMBO J; 1998 Apr; 17(7):1907-18. PubMed ID: 9524114
[TBL] [Abstract][Full Text] [Related]
20. Yersinia enterocolitica can deliver Yop proteins into a wide range of cell types: development of a delivery system for heterologous proteins.
Boyd AP; Grosdent N; Tötemeyer S; Geuijen C; Bleves S; Iriarte M; Lambermont I; Octave JN; Cornelis GR
Eur J Cell Biol; 2000 Oct; 79(10):659-71. PubMed ID: 11089914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
